Predictive, preventive and personalised approach as a conceptual and technological innovation in primary and secondary care of inflammatory bowel disease benefiting affected individuals and populations.

"Declarations Ethics approvalNot applicable. Consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding Open Access funding enabled and organized by Projekt DEAL. The research of JCA is funded by the Instituto de Salud Carlos III through the ‘Miguel Servet’ Program (CP19/00172), by the Fondo Social Europeo (FSE) (PI21/00880) and Axencia Galega de Innovación-Proxectos de Excelencia (IN607D 2022/03). LA work is funded by the Xunta de Galicia under the ‘Investigo Program’ (TR 349 V) and the ‘Axencia Galega de Innovación’. MCG is the recipient of a predoctoral fellowship funded by the Health Research Insititute of Santiago de Compostela (IDIS)."